knowledge -WSS

knowledge

author：focus 2025-09-03 11:49:28 - browse：129

ITeos Therapeutics offered the first look at clinical data for its experimental cancer antibody that works by blocking the novel — and very buzzworthy — protein target called TIGIT.

The tumor-shrinking activity of the company’s drug, called EOS-448, was minimal but still comparable to early study data from competing TIGIT-targeted drugs in development, including ones from Roche and Merck.

iTeos presented the EOS-448 Phase 1 study results at the annual meeting of the American Association for Cancer Research on Saturday.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Overprescribed: High cost isn't America's only drug problem

WSS

Verily hires former Apple Health leader as chief scientific officer

Young boy dies in trial for Pfizer Duchenne gene therapy

Florida Supreme Court upholds state's abortion ban

Trial using CRISPR to edit HIV out of cells disappoints

'Ancient DNA,' 23andMe reveal African American ancestries

Florida Supreme Court upholds state's abortion ban

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Cancer drug shortages should be causing more outrage

Harvard scientists, with Google, unveil the most detailed brain map ever

Guidelines to prevent youth baseball injuries need more muscle

2 US Navy sailors arrested for allegedly spying for China

Guidelines to prevent youth baseball injuries need more muscle

Pancreatic cancer is often deadly, but new discoveries are raising hope

Moonlake's readout produced a cash windfall. Risks remain

Republican states more likely to report Covid vaccine side effects

Virginia high school admissions case could be legal follow

U.K. decision on ALS drug has neurologists, advocates up in arms

focus

What Henrietta Lacks settlement says about racism in medicine

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

ER docs worry over extreme heat as a 'mass casualty event'

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Young boy dies in trial for Pfizer Duchenne gene therapy

knowledge

leisure time

focus

leisure time